Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;41(6 Suppl 1):6S57-60.
doi: 10.1016/S0013-7006(16)30012-4.

[Negative symptoms in schizophrenia: psychotherapeutic approaches]

[Article in French]
Affiliations
Review

[Negative symptoms in schizophrenia: psychotherapeutic approaches]

[Article in French]
J-M Azorin et al. Encephale. 2015 Dec.

Abstract

Although negative symptoms are recognized as a central feature of schizophrenia, their definition as well as phenomenology have long been a vexing issue. During these last years, a major progress has been made with the delineation of two underlying subdomains of negative symptoms: diminished expression and anhedonia-avolition-apathy. As current guidelines are not always in accord on the efficacy of treatments on negative symptoms, it may be tempting to re-interpret the findings of clinical trials by looking at the effects of treatments on these two subdomains. This could concern both psychotropic treatments and psychotherapeutic interventions. Furthermore, neuroimaging as well as emotional response studies have permitted to better understand the mechanism which could be at the root of diminished expression and anhedonia in schizophrenia. On this basis, new psychotherapeutic methods have been devised which, by specifically targeting these two subdomains, are likely to be more efficient on negative symptoms. Further research is warranted to test their efficacy in randomized controlled trials.

Keywords: Anhedonia; Anhédonie; Apathie; Apathy; Avolition; Negative symptoms; Psychotherapy; Psychothérapie; Symptômes négatifs.

PubMed Disclaimer

Substances